AFC-TAB-011

antibody from Creative Biolabs

Targeting: VEGFA VEGF, VEGF-A, VPF

No application information provided.

Antibody Data

Product number

AFC-TAB-011

Provider

Creative Biolabs

Product name

Afuco? Anti-VEGFA ADCC Recombinant Antibody (Bevacizumab), ADCC Enhanced

Antibody type

Monoclonal

Description

This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant monoclonal antibody to Human VEGF is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. It is licensed to treat various cancers, including colorectal, lung, breast (outside the USA), glioblastoma (USA only), kidney and ovarian. Bevacizumab is a humanized monoclonal antibody that produces angiogenesis inhibition by inhibiting vascular endothelial growth factor A (VEGF-A). VEGF-A is a chemical signal that stimulates angiogenesis in a variety of diseases, especially in cancer.

Reactivity

Human

Conjugate

Unconjugated

Antibody clone number

Bevacizumab

Storage

Store at +4¡ãC short term (1-2 weeks). Aliquot and store at -20¡ãC long term. Avoid repeated freeze/thaw cycles.